Nicotine Lozenge Receives FDA Approval November 4, 2002
News Summary
For the first time ever, the U.S. Food and Drug Administration (FDA) has given its approval for an over-the-counter lozenge containing nicotine, the Associated Press reported Nov. 1.The nicotine lozenge, produced by GlaxoSmithKline, is designed to reduce cigarette cravings.
Called Commit, the lozenge comes in varying doses of nicotine. How long a smoker goes between cigarettes determines the strength they should use, according to the manufacturer.
The lozenges are expected to be on the market in December. A pack of 72 lozenges will sell for about $39.95.
COMMENTS ON THIS ARTICLE: